Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C24H23NO |
| Molecular Weight | 341.4455 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCN1C=C(C(=O)C2=CC=CC3=CC=CC=C23)C4=C1C=CC=C4
InChI
InChIKey=JDNLPKCAXICMBW-UHFFFAOYSA-N
InChI=1S/C24H23NO/c1-2-3-8-16-25-17-22(20-13-6-7-15-23(20)25)24(26)21-14-9-11-18-10-4-5-12-19(18)21/h4-7,9-15,17H,2-3,8,16H2,1H3
| Molecular Formula | C24H23NO |
| Molecular Weight | 341.4455 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionCurator's Comment: description was created based on several sources, including:
https://psychonautwiki.org/wiki/JWH-018 | https://en.wikipedia.org/wiki/JWH-018
Curator's Comment: description was created based on several sources, including:
https://psychonautwiki.org/wiki/JWH-018 | https://en.wikipedia.org/wiki/JWH-018
JWH-018 is a full agonist synthetic cannabinoid with a high binding affinity to CB1 and CB2 cannabinoid receptors. JWH-018 has not been used in therapy. Many of the risks linked to cannabis use are also present in the case of JWH-018, among them complications in patients suffering from cardiovascular diseases and triggering of acute psychosis. JWH-018 has not been used in therapy. Studies in mice showed anti-inflammatory and cancer chemopreventive properties of JWH-018.
CNS Activity
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL218 Sources: https://www.ncbi.nlm.nih.gov/pubmed/10940540 |
9.0 nM [Ki] | ||
Target ID: CHEMBL253 Sources: https://www.ncbi.nlm.nih.gov/pubmed/10940540 |
2.94 nM [Ki] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Preventing | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Cytotoxicity of synthetic cannabinoids on primary neuronal cells of the forebrain: the involvement of cannabinoid CB1 receptors and apoptotic cell death. | 2014-01-01 |
|
| Toxicological profiles of selected synthetic cannabinoids showing high binding affinities to the cannabinoid receptor subtype CB₁. | 2013-07 |
|
| Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors. | 2013-06-01 |
|
| In vitro phase I metabolism of the synthetic cannabimimetic JWH-018. | 2010-11 |
|
| Sensitive and rapid quantification of the cannabinoid receptor agonist naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) in human serum by liquid chromatography-tandem mass spectrometry. | 2010-10-01 |
|
| Warning: legal synthetic cannabinoid-receptor agonists such as JWH-018 may precipitate psychosis in vulnerable individuals. | 2010-10 |
|
| Detection of JWH-018 metabolites in smoking mixture post-administration urine. | 2010-07-15 |
|
| A teenager with agitation: higher than she should have climbed. | 2010-06 |
|
| JWH018, a common constituent of 'Spice' herbal blends, is a potent and efficacious cannabinoid CB receptor agonist. | 2010-06 |
|
| Chemical analysis of synthetic cannabinoids as designer drugs in herbal products. | 2010-05-20 |
|
| Discriminative stimulus functions of methanandamide and delta(9)-THC in rats: tests with aminoalkylindoles (WIN55,212-2 and AM678) and ethanol. | 2010-01 |
Patents
Sample Use Guides
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:36:09 GMT 2025
by
admin
on
Mon Mar 31 21:36:09 GMT 2025
|
| Record UNII |
G391998J57
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-JWH-018
Created by
admin on Mon Mar 31 21:36:09 GMT 2025 , Edited by admin on Mon Mar 31 21:36:09 GMT 2025
|
||
|
DEA NO. |
7118
Created by
admin on Mon Mar 31 21:36:09 GMT 2025 , Edited by admin on Mon Mar 31 21:36:09 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID10175117
Created by
admin on Mon Mar 31 21:36:09 GMT 2025 , Edited by admin on Mon Mar 31 21:36:09 GMT 2025
|
PRIMARY | |||
|
300000040178
Created by
admin on Mon Mar 31 21:36:09 GMT 2025 , Edited by admin on Mon Mar 31 21:36:09 GMT 2025
|
PRIMARY | |||
|
G391998J57
Created by
admin on Mon Mar 31 21:36:09 GMT 2025 , Edited by admin on Mon Mar 31 21:36:09 GMT 2025
|
PRIMARY | |||
|
C552597
Created by
admin on Mon Mar 31 21:36:09 GMT 2025 , Edited by admin on Mon Mar 31 21:36:09 GMT 2025
|
PRIMARY | |||
|
JWH-018
Created by
admin on Mon Mar 31 21:36:09 GMT 2025 , Edited by admin on Mon Mar 31 21:36:09 GMT 2025
|
PRIMARY | |||
|
209414-07-3
Created by
admin on Mon Mar 31 21:36:09 GMT 2025 , Edited by admin on Mon Mar 31 21:36:09 GMT 2025
|
PRIMARY | |||
|
7998
Created by
admin on Mon Mar 31 21:36:09 GMT 2025 , Edited by admin on Mon Mar 31 21:36:09 GMT 2025
|
PRIMARY | |||
|
10382701
Created by
admin on Mon Mar 31 21:36:09 GMT 2025 , Edited by admin on Mon Mar 31 21:36:09 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> AGONIST |
Mouse AtT-20 neuroblastoma cells stably transfected with human CB1
EC50
|
||
|
|
TARGET -> AGONIST |
Mouse AtT-20 neuroblastoma cells stably transfected with human CB2
EC50
|